Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

A subanalgesic dose of morphine eliminates nalbuphine anti-analgesia in postoperative pain.

Gear RW, Gordon NC, Hossaini-Zadeh M, Lee JS, Miaskowski C, Paul SM, Levine JD.

J Pain. 2008 Apr;9(4):337-41. doi: 10.1016/j.jpain.2007.11.011. Epub 2008 Jan 16.

2.

Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans.

Gear RW, Gordon NC, Miaskowski C, Paul SM, Heller PH, Levine JD.

Neurosci Lett. 2003 Nov 6;351(1):5-8. Erratum in: Neurosci Lett. 2012 Sep 13;525(2):184.

PMID:
14550900
3.

The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain.

Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD.

Pain. 1999 Nov;83(2):339-45.

PMID:
10534607
4.

Sexual dimorphism in very low dose nalbuphine postoperative analgesia.

Gear RW, Gordon NC, Miaskowski C, Paul SM, Heller PH, Levine JD.

Neurosci Lett. 2003 Mar 13;339(1):1-4.

PMID:
12618286
5.
6.

NOP receptor mediates anti-analgesia induced by agonist-antagonist opioids.

Gear RW, Bogen O, Ferrari LF, Green PG, Levine JD.

Neuroscience. 2014 Jan 17;257:139-48. doi: 10.1016/j.neuroscience.2013.10.061. Epub 2013 Nov 1.

7.

Absence of nalbuphine anti-analgesia in the rat.

Khasar SG, Gear RW, Levine JD.

Neurosci Lett. 2003 Jul 24;345(3):165-8.

PMID:
12842282
8.

Nalbuphine for postoperative pain treatment in children.

Schnabel A, Reichl SU, Zahn PK, Pogatzki-Zahn E.

Cochrane Database Syst Rev. 2014 Jul 31;(7):CD009583. doi: 10.1002/14651858.CD009583.pub2. Review.

PMID:
25079857
9.

Nalbuphine.

Schmidt WK, Tam SW, Shotzberger GS, Smith DH Jr, Clark R, Vernier VG.

Drug Alcohol Depend. 1985 Feb;14(3-4):339-62. Review.

PMID:
2986929
10.

Neuroleptics antagonize nalbuphine antianalgesia.

Gear RW, Lee JS, Miaskowski C, Gordon NC, Paul SM, Levine JD.

J Pain. 2006 Mar;7(3):187-91.

PMID:
16516824
11.
12.

Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.

Pick CG, Paul D, Pasternak GW.

J Pharmacol Exp Ther. 1992 Sep;262(3):1044-50.

PMID:
1326621
13.

Combination of low-dose nalbuphine and morphine in patient-controlled analgesia decreases incidence of opioid-related side effects.

Yeh YC, Lin TF, Chang HC, Chan WS, Wang YP, Lin CJ, Sun WZ.

J Formos Med Assoc. 2009 Jul;108(7):548-53. doi: 10.1016/S0929-6646(09)60372-7.

14.

Opioid agonist-antagonist drugs in acute and chronic pain states.

Hoskin PJ, Hanks GW.

Drugs. 1991 Mar;41(3):326-44. Review.

PMID:
1711441
15.

Naloxone versus nalbuphine infusion for prophylaxis of epidural morphine-induced pruritus.

Kendrick WD, Woods AM, Daly MY, Birch RF, DiFazio C.

Anesth Analg. 1996 Mar;82(3):641-7.

PMID:
8623975
16.
17.

Antagonistic effect of MR2266 and MR2267 on morphine or nalbuphine analgesia at the spinal levels in rats.

Kmieciak-Kołada K, Spiewak Z, Urbanowicz A, Pawłowski J, Herman ZS.

Pol J Pharmacol. 1995 Nov-Dec;47(6):509-18.

PMID:
8868373
18.

Kappa-opioids produce significantly greater analgesia in women than in men.

Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD.

Nat Med. 1996 Nov;2(11):1248-50.

PMID:
8898754
19.
20.

Supplemental Content

Support Center